SOURCE: MyDx, Inc.

MyDx, Inc. Logo

July 16, 2015 18:59 ET

MyDx Names Tom Gruber as New CEO

SAN DIEGO, CA--(Marketwired - July 16, 2015) - MyDx, Inc. (OTCQB: MYDX), creator of MyDx™ (My Diagnostic), the first battery operated, handheld, chemical analyzer for consumers, has appointed Tom Gruber as the new Chief Executive Officer effective July 10, 2015.

Tom is currently the company's Chief Financial Officer and Chief Operating Officer and will continue to serve on MyDx's board of directors as board secretary. Gruber brings more than 20 years of financial and senior executive management experience, having served as CFO of Western Digital, as well as President and CFO of nStor Technologies, Inc.

"The vision of enabling consumers with the ability to measure and analyze chemicals of interest in their own homes for the first time in history was very compelling to me," said Gruber. "I am excited to move MyDx forward as the leader in consumer sensing technologies enabling anyone to understand more about what they eat, drink and inhale."

Tom succeeds Daniel Yazbeck, who founded MyDx in 2013 and seeded the initial capital and resources to drive the company's vision from concept to implementation. Mr. Yazbeck will continue to serve as the Chairman of the Board of Directors and has been appointed as Chief Innovation Officer to help advance the company's new applications and next-generation technologies.

"With the help of my team during my time as CEO, we successfully created and launched our first product, established a brand, and became a publically traded company," said Yazbeck. "Tom has the full support of the executive management team as well as the board of directors and I am grateful and excited to see MyDx continue to grow under his leadership."

About MyDx, Inc.

MyDx, Inc. (OTCQB: MYDX) is a science and technology company based in San Diego, California whose mission is to help people Trust & Verify™ what they put into their minds and bodies. The Company has developed MyDx™, an affordable portable analyzer that provides real-time chemical analysis and fits in the palm of your hands. MyDx™ leverages over a decade of established electronic nose technology to measure chemicals of interest and has four sensors being developed in its lab that are compatible with the MyDx™ Analyzer and App. For more information, please visit

Safe Harbor

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may", "will", "expect", "believe", "anticipate", "estimate", "intends", "goal", "objective", "seek", "attempt", or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at

Contact Information